Compare TRMD & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRMD | OMCL |
|---|---|---|
| Founded | 1889 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Computer Manufacturing |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | N/A | 2001 |
| Metric | TRMD | OMCL |
|---|---|---|
| Price | $24.20 | $48.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $23.00 | ★ $49.83 |
| AVG Volume (30 Days) | ★ 574.8K | 430.9K |
| Earning Date | 03-05-2026 | 02-05-2026 |
| Dividend Yield | ★ 8.31% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.76 | 0.43 |
| Revenue | ★ $1,292,300,000.00 | $1,177,740,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | N/A | $4.30 |
| P/E Ratio | ★ $8.80 | $115.39 |
| Revenue Growth | N/A | ★ 10.67 |
| 52 Week Low | $13.60 | $22.66 |
| 52 Week High | $24.95 | $55.00 |
| Indicator | TRMD | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 68.06 | 52.77 |
| Support Level | $22.09 | $48.05 |
| Resistance Level | $24.95 | $50.70 |
| Average True Range (ATR) | 0.65 | 1.39 |
| MACD | 0.18 | -0.55 |
| Stochastic Oscillator | 75.94 | 14.91 |
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.